News | EP Mapping and Imaging Systems | October 29, 2018

First Carto Vizigo Bi-Directional Guiding Sheath Employed on West Coast

Sheath can be visualized on Carto 3 system during catheter ablation to reduce dependence on fluoroscopy

First Carto Vizigo Bi-Directional Guiding Sheath Employed on West Coast

October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto Vizigo bi-directional guiding sheath. The sheath can be visualized on the Carto 3 System during a catheter ablation procedure, helping electrophysiologists reduce dependency on fluoroscopy.

A sheath is an introducer routinely used by physicians to facilitate catheter access, stability and tissue contact when targeting sites for catheter ablation to treat arrhythmias. Electrophysiologists rely on fluoroscopy to identify the location of the sheath, therefore requiring use of lead to protect themselves from radiation during the procedure.

According to Ivan Ho, M.D., electrophysiologist practicing at Good Samaritan Hospital and the first to use the technology on the West Coast, the long deflectable sheath has become a major step forward in achieving catheter stability and appropriate radiofrequency energy delivery in complex left-sided arrhythmia ablations. "One of the limitations has been the need of periodic fluoroscopic imaging of the sheath's relative position with the catheter to optimize contact with endocardial surface and ensure safety due to the relatively stiff shaft of these sheaths," said Ho.  The Vizigo allows the direction of the sheath and its relationship with the catheter to be visualized accurately on a 3-D mapping system, minimizing the use of fluoroscopy and overall procedure time.

This new technology is incorporated easily into the physicians' workflow, designed to enhance efficiency during mapping and positioning of the ablation catheter. The smooth tip-to-dilator transition promotes ease of entry into the left atrium during transseptal access, while deflections of 180 degrees in both directions mean increased steerability, which may improve access to hard-to-reach sites.

For more information: www.biosensewebster.com

Related Content

First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019
Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter,...
First Patient Treated in STELLAR Atrial Fibrillation IDE Study
News | Ablation Systems | November 30, 2018
Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and treated the first...
FDA Approves Biosense Webster's Tag-Index Guided Ablation Software
Technology | Ablation Systems | October 09, 2018
Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for its Visitag...
Medtronic Cryoballoon Improves Quality of Life, Reduces Systems of Persistent Atrial Fibrillation
News | Ablation Systems | August 28, 2018
Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life...
Thermedical Announces FDA IDE Approval for Clinical Study of Durablate Catheter
News | Ablation Systems | August 02, 2018
Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device...
Boston Scientific to Acquire Cryterion Medical Inc.
News | Ablation Systems | July 13, 2018
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held...
Treating AFib With Ablation Reduces Mortality and Stroke
News | Ablation Systems | July 05, 2018
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the...
LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018
LuxCath LLC showcased the next generation of its proprietary OmniView light-guided catheter ablation system at the 2018...
The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.  #HRS2018

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously. 

News | Ablation Systems | May 21, 2018
May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-in
Overlay Init